InnoCare Pharma Catalyst Calendar
Proactively evaluate InnoCare Pharma Ltd’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.
A sample of InnoCare Pharma Catalyst Calendar data
Event Date | Event Type | Company Name | Ticker Symbol | Drug Name | Therapy Area | Indication | Source Type |
---|---|---|---|---|---|---|---|
20 Oct 2020 | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Lorem |
28 Jul 2020 | Phase II Trial Initiation | CMAX Clinical Research Pty Ltd; Innocare Pharma Australia Pty Ltd | - | orelabrutinib | Immunology | Rheumatoid Arthritis; Systemic Lupus Erythematosus | GD Estimates |
20 Jun 2020 | Phase I/II Trial Initiation | InnoCare Pharma Ltd | 9969 | orelabrutinib | Oncology | B-Cell Non-Hodgkin Lymphoma; Chronic Lymphocytic Leukemia (CLL); Unspecified B-Cell Lymphomas | Clinical Trial Registry |
01 Apr 2020 | Phase I/II Trial Initiation | InnoCare Pharma Ltd | 9969 | orelabrutinib | Immunology | Systemic Lupus Erythematosus | Clinical Trial Registry |
Feature
Catalyst Calendar provides forecasted drug development milestones within the Pharma industry including expected timing, expected outcomes and possible financial impacts.
Benefit
Access:
- Trial Events for trials conducted globally by a company, university, institute or CRO: Trial Initiation, Trial Completion, Trial Results
- Regulatory Events related to drug filings with regulatory bodies, approvals and commercial launches. This is covered for the US, EU and Japan
- Intellectual Property Events for patent and exclusivity expiry specific to the US, EU and Japan: Constraining Patent Expiry (US/EU/Japan), Drug Expiry (US/EU/Japan), Commercial Launch (US/EU/Japan)
Value
Proactively evaluate companies and catalyst impacts
Stay ahead of the competition & improve corporate planning
Bolster business development with timely opportunities
Premium databases is part of our industry range of products
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer